Skip to content
PICO Portalanswers from OpenAlex

Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea

PaperCitations, authors & open-access status

Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea is a paper indexed in PICO Portal from OpenAlex.

How many citations does Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea have?

PICO Portalcitation count

Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea has 24 citations in the OpenAlex counts PICO Portal stores.

When was Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea published?

PICO Portalyear

Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea has 2016 year in the PICO Portal index.

What is the open-access status of Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea?

PICO Portaloa status

Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea has closed oa status in the PICO Portal index.

What is the DOI of Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea?

PICO Portaldoi

The DOI for Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea is on the source record.

What is the PMID of Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea?

PICO Portalpmid

The PMID for Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea is on the source record.

What is the OpenAlex record for Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea?

PICO Portalopenalex

The OpenAlex for Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial